Karin Westlund High

Title: Innovations in Pain Management by Karin Westlund High

Introduction

Karin Westlund High is an accomplished inventor based in Albuquerque, NM (US). She has made significant contributions to the field of pain management through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing compositions that utilize antibodies to alleviate pain.

Latest Patents

One of her latest patents is titled "Compositions comprising antibodies or antibody fragments which bind the P2X4 receptor." This composition is designed for treating pain and includes an antibody or antibody fragment that specifically binds to a receptor involved in pain, particularly the P2X4 receptor. The composition may also include a detectable marker, such as a fluorescent tag, which can be used to treat both acute and chronic pain in subjects. The methods outlined in this patent involve administering a composition that can reverse pain-related behaviors in various pain models.

Another notable patent is "Therapeutic antibody fragments, methods of making, and methods of use." This pharmaceutical composition includes a therapeutic antibody or its fragment, along with a pharmaceutically acceptable carrier. The therapeutic antibody specifically targets a peptide that mediates pain, providing a means to alleviate pain in subjects experiencing discomfort.

Career Highlights

Karin has worked with prestigious institutions such as the University of New Mexico and Loyola University of Chicago. Her research has been pivotal in advancing the understanding of pain mechanisms and developing non-opioid pain relief solutions.

Collaborations

Throughout her career, Karin has collaborated with notable colleagues, including Adinarayana Kunamneni and Ravi Durvasula. These partnerships have further enriched her research and contributed to her innovative work in pain management.

Conclusion

Karin Westlund High's contributions to the field of pain management through her patented inventions demonstrate her commitment to improving therapeutic options for patients. Her innovative approaches continue to pave the way for advancements in non-opioid pain relief.